The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation
Open accessAbstract
Hepatitis C virus (HCV) is an important human pathogen that is remarkably efficient at establishing persistent infection. The HCV core protein is the first protein expressed during the early phase of HCV infection. Our previous work demonstrated that the HCV core protein suppresses host immune responses, including anti-viral cytotoxic T-lymphocyte responses in a murine model. To investigate the mechanism of HCV core-mediated immunosuppression, we searched for host proteins capable of associating with the core protein using a yeast two-hybrid system. Using the core protein as bait, we screened a human T cell-enriched expression library and identified a gene encoding the gC1q receptor (gC1qR). C1q is a ligand of gC1qR and is involved in the early host defense against infection. Like C1q, HCV core can inhibit T-cell proliferative responses in vitro. This core-induced anti-T-cell proliferation is reversed by addition of anti-gC1qR Ab in a T-cell proliferation assay. Furthermore, biochemical analysis of the interaction between core and gC1qR indicates that HCV core binds the region spanning amino acids 188 to 259 of gC1qR, a site distinct from the binding region of C1q. The inhibition of T-cell responsiveness by HCV core may have important implications for HCV persistence in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome
Choo, Q.-L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W., & Houghton, M. (1989) · Science · doi:10.1126/science.2523562 · Cited by 6,875
Schaff, Z., & Csmos, G. (1994) · Cited by 1,868
Chien, C. T., Bartel, P. L., Sternglanz, R., & Fields, S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.21.9578 · Cited by 1,492
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies
Botto, M., Dell' Agnola, C., Bygrave, A. E., Thompson, E. M., Cook, H. T., Petry, F., Loos, M., Pandolfi, P. P., & Walport, M. J. (1998) · Nature Genetics · doi:10.1038/ng0598-56 · Cited by 1,434
Hepatitis C virus infection is associated with the development of hepatocellular carcinoma.
Saito, I., Miyamura, T., Ohbayashi, A., Harada, H., Katayama, T., Kikuchi, S., Watanabe, Y., Koi, S., Onji, M., & Ohta, Y. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.17.6547 · Cited by 1,089
Alter, M. J. (1997) · Hepatology · doi:10.1002/hep.510260711 · Cited by 1,075
Expression and identification of hepatitis C virus polyprotein cleavage products
Grakoui, A., Wychowski, C., Lin, C., Feinstone, S. M., & Rice, C. M. (1993) · Journal of Virology · doi:10.1128/jvi.67.3.1385-1395.1993 · Cited by 898
Membranoproliferative Glomerulonephritis Associated with Hepatitis C Virus Infection
Johnson, R. J., Gretch, D. R., Yamabe, H., Hart, J., Bacchi, C. E., Hartwell, P., Couser, W. G., Corey, L., Wener, M. H., Alpers, C. E., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199302183280703 · Cited by 879
Houghton, M., Weiner, A., Han, J., Kuo, G., & Choo, Q.-L. (1991) · Hepatology · doi:10.1002/hep.1840140227 · Cited by 863
Brodie, S. E. (1996) · Survey of Ophthalmology · doi:10.1016/s0039-6257(96)80075-0 · Cited by 745
Cited by
Immunology of hepatitis B virus and hepatitis C virus infection
Rehermann, B., & Nascimbeni, M. (2005) · Nature Reviews Immunology · doi:10.1038/nri1573 · Cited by 1,627
Structural biology of hepatitis C virus
Penin, F., Dubuisson, J., Rey, F. A., Moradpour, D., & Pawlotsky, J.-M. (2004) · Hepatology · doi:10.1002/hep.20032 · Cited by 683
Hepatic T cells and liver tolerance
Crispe, I. N. (2003) · Nature Reviews Immunology · doi:10.1038/nri981 · Cited by 661
Wedemeyer, H., He, X.-S., Nascimbeni, M., Davis, A. R., Greenberg, H. B., Hoofnagle, J. H., Liang, T. J., Alter, H., & Rehermann, B. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.6.3447 · Cited by 634
Perlemuter, G., Sabile, A., Letteron, P., Vona, G., Topilco, A., Chrétien, Y., Koike, K., Pessayre, D., Chapman, J., Barba, G., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-0396com · Cited by 584
Molecular viral oncology of hepatocellular carcinoma
Block, T. M., Mehta, A. S., Fimmel, C. J., & Jordan, R. (2003) · Oncogene · doi:10.1038/sj.onc.1206557 · Cited by 495
Viral hepatitis and liver cancer: the case of hepatitis C
Levrero, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209562 · Cited by 404
Flying Under the Radar: The Immunobiology of Hepatitis C
Dustin, L. B., & Rice, C. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141602 · Cited by 313
Accapezzato, D., Francavilla, V., Paroli, M., Casciaro, M., Chircu, L. V., Cividini, A., Abrignani, S., Mondelli, M. U., & Barnaba, V. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420515 · Cited by 303
Pathways for bradykinin formation and inflammatory disease
Kaplan, A. P., Joseph, K., & Silverberg, M. (2002) · Journal of Allergy and Clinical Immunology · doi:10.1067/mai.2002.121316 · Cited by 302
Macedo, A. C. L., & Isaac, L. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00055 · Cited by 290
Complement and viral pathogenesis
Stoermer, K. A., & Morrison, T. E. (2011) · Virology · doi:10.1016/j.virol.2010.12.045 · Cited by 255
Kinetics of the Immune Response During Hbv and Hcv Infection
Bertoletti, A., & Ferrari, C. (2003) · Hepatology · doi:10.1053/jhep.2003.50310 · Cited by 254
Bataller, R., Paik, Y.-H., Lindquist, J. N., Lemasters, J. J., & Brenner, D. A. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.018 · Cited by 252
Ruiz-Molina, N., Parsons, J., Decker, E. L., & Reski, R. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.02.002 · Cited by 4
Metadata
- Authors
- Kittlesen, D. J., Chianese-Bullock, K. A., Yao, Z. Q., Braciale, T. J., & Hahn, Y. S.
- Venue
- Journal of Clinical Investigation
- Published
- 2000-11-15
- Volume
- 106
- Issue
- 10
- Pages
- 1239-1249
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2072681498
- Cited by
- 333
- References
- 46
- FWCI
- 10.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.